Stock RDHL REDHILL BIOPHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company RedHill Biopharma Ltd.

Equities

RDHL

US7574682024

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
0.4827 USD +4.93% Intraday chart for RedHill Biopharma Ltd. +5.39% -66.94%
May. 06 Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib MT
May. 06 RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 CI

Business Summary

RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.

Number of employees: 53

Sales per Business

USD in Million2022Weight2023Weight Delta
Commercial
100.0 %
62 100.0 % 7 100.0 % -89.43%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
62 100.0 % 7 100.0 % -89.43%

Managers

Managers TitleAgeSince
Dror Ben-Asher CEO
 Chief Executive Officer 59 09-08-02
Ori Shilo FOU
 Founder 58 09-08-02
Razi Ingber DFI
 Director of Finance/CFO - 23-01-04
Gilead Raday COO
 Chief Operating Officer 49 10-11-09
Ira N. Kalfus CTO
 Chief Tech/Sci/R&D Officer 63 -
Reza Fathi CTO
 Chief Tech/Sci/R&D Officer 69 10-04-30
kristin Comer CMP
 Compliance Officer - -
June Almenoff CTO
 Chief Tech/Sci/R&D Officer 67 19-05-27
Mark L. Levitt CTO
 Chief Tech/Sci/R&D Officer - 16-12-31
Terry F. Plasse CTO
 Chief Tech/Sci/R&D Officer - -

Members of the board

Members of the board TitleAgeSince
Rick Scruggs BRD
 Director/Board Member 64 15-12-31
Shmuel Cabilly BRD
 Director/Board Member 74 10-08-25
Eric Emile Swenden BRD
 Director/Board Member 80 10-05-02
Alla Felder BRD
 Director/Board Member 50 19-05-05
Dror Ben-Asher CEO
 Chief Executive Officer 59 09-08-02
Kenneth Reed BRD
 Director/Board Member 70 09-12-14
Ofer Tsimchi BRD
 Director/Board Member 64 11-05-03

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 7,869,853,000 7,791,154,470 ( 99.00 %) 0 99.00 %

Shareholders

NameEquities%Valuation
Sabby Management LLC
7.278 %
2,319,238 7.278 % 964 803 $
Heights Capital Management, Inc.
5.492 %
1,750,000 5.492 % 728 000 $
Gagnon Securities LLC
0.3714 %
118,360 0.3714 % 49 238 $
Jane Street Group LLC
0.2724 %
86,812 0.2724 % 36 114 $
Desjardins Securities, Inc.
0.2459 %
78,357 0.2459 % 32 597 $
UBS Securities LLC
0.1585 %
50,521 0.1585 % 21 017 $
RhumbLine Advisers LP
0.0947 %
30,187 0.0947 % 12 558 $
MGO One Seven LLC
0.0494 %
15,750 0.0494 % 6 552 $
Two Sigma Securities LLC
0.0362 %
11,550 0.0362 % 4 805 $
Group One Trading LP
0.001930 %
615 0.001930 % 256 $
NameEquities%Valuation
R&S United Services, Inc.
17.09 %
2,030,472,000 17.09 % 84 M $
Kenneth Reed
0.0657 %
7,805,250 0.0657 % 324 698 $
Shmuel Cabilly
0.0438 %
5,201,270 0.0438 % 216 373 $
Dror Ben-Asher
0.0329 %
3,910,620 0.0329 % 162 682 $
Adi Frish
0.0223 %
2,650,720 0.0223 % 110 270 $
Gilead Raday
0.0206 %
2,448,400 0.0206 % 101 853 $
Reza Fathi
0.0152 %
1,800,800 0.0152 % 74 913 $
Razi Ingber
0.0141 %
1,678,800 0.0141 % 69 838 $
Guy Goldberg
0.0139 %
1,645,600 0.0139 % 68 457 $
Intracoastal Capital LLC
0.0105 %
1,250,000 0.0105 % 52 000 $

Company contact information

RedHill Biopharma Ltd.

21 Ha'arba'a Street

6473921, Tel Aviv

+972 3 541 3131

http://www.redhillbio.com
address RedHill Biopharma Ltd.(RDHL)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Quarterly earnings - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
REDHILL BIOPHARMA LTD. Stock RedHill Biopharma Ltd.
-66.94% 15.38M
CSL LIMITED Stock CSL Limited
-2.32% 92.59B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+3.16% 41.43B
BIOGEN INC. Stock Biogen Inc.
-11.10% 33.49B
UCB Stock UCB
+53.49% 25.06B
INCYTE CORPORATION Stock Incyte Corporation
-9.41% 12.77B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.25% 11.58B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-44.00% 11.35B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+6.07% 8.97B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-6.32% 8.3B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. RDHL Stock
  4. Company RedHill Biopharma Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW